{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:28Z","timestamp":1741238668759,"version":"3.38.0"},"reference-count":22,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.nephro.2017.03.004","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T11:55:01Z","timestamp":1519905301000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Le cyclophosphamide dans le syndrome n\u00e9phrotique idiopathique\u00a0: r\u00e9sultats et perspectives"],"prefix":"10.1684","volume":"14","author":[{"given":"Majda","family":"Berkane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latifa","family":"Adarmouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Amine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aicha","family":"Bourrahouat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Ait Sab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Sbihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2017.03.004_bib0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.arcped.2004.12.015","article-title":"Immunit\u00e9 cellulaire et traitement immunosuppresseur du syndrome n\u00e9phrotique idiopathique de l\u2019enfant","volume":"12","author":"Frange","year":"2005","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.nephro.2017.03.004_bib0120","series-title":"Pediatric nephrology","first-page":"543","article-title":"Steroid-sensitive nephrotic syndrome in children","author":"Niaudet","year":"2004"},{"key":"10.1016\/j.nephro.2017.03.004_bib0125","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00467-005-1968-8","article-title":"Evidence-based management of steroid-sensitive nephrotic syndrome","volume":"20","author":"Hodson","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.03.004_bib0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0929-693X(12)71205-8","article-title":"Place actuelle du cyclophosphamide dans le syndrome n\u00e9phrotique idiopathique de l\u2019enfant","volume":"19","author":"Harambat","year":"2012","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.nephro.2017.03.004_bib0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(70)90108-X","article-title":"Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood","volume":"2","author":"Barratt","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2017.03.004_bib0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00467-003-1170-9","article-title":"Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook","volume":"18","author":"Vester","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.03.004_bib0145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nephro.2005.06.003","article-title":"Corticosensitive nephrotic syndrome (or nephrosis) in children. Therapeutic guideline proposed by the Pediatric Society of Nephrology","volume":"1","author":"B\u00e9rard","year":"2005","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2017.03.004_bib0150","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","article-title":"Long-term outcome of idiopathic steroid resistant nephrotic syndrome: a multicenter study","volume":"24","author":"Mekahli","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.03.004_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/S1637-5017(08)72418-9","article-title":"Syndrome n\u00e9phrotique chez l\u2019enfant","author":"Niaudet","year":"2008"},{"issue":"suppl. 2","key":"10.1016\/j.nephro.2017.03.004_bib0160","doi-asserted-by":"crossref","first-page":"142s","DOI":"10.1016\/S0929-693X(98)81274-8","article-title":"Traitement de la n\u00e9phrose de l\u2019enfant","volume":"5","author":"Loirat","year":"1998","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.nephro.2017.03.004_bib0165","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.arcped.2008.08.020","article-title":"Corticoth\u00e9rapie prolong\u00e9e chez l\u2019enfant\u00a0: quelle place pour un traitement adjuvant dans le syndrome n\u00e9phrotique\u00a0?","volume":"15","author":"Bachetta","year":"2008","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.nephro.2017.03.004_bib0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-011-1825-x","article-title":"Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome","volume":"26","author":"Zagury","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.03.004_bib0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/ndt\/gfq405","article-title":"Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"26","author":"Cammas","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.03.004_bib0180","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.ajkd.2007.02.270","article-title":"Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome","volume":"49","author":"Kyrieleis","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.03.004_bib0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004670000523","article-title":"A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children","volume":"16","author":"Latta","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.03.004_bib0190","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/adc.62.11.1102","article-title":"Cyclophosphamide treatment of steroid-dependent nephrotic syndrome: comparison of eight week with 12-week course. Report of Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","volume":"62","author":"Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","year":"1987","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nephro.2017.03.004_bib0195","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/adc.48.4.286","article-title":"Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood","volume":"48","author":"Barratt","year":"1973","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nephro.2017.03.004_bib0200","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.291.6507.1457","article-title":"Long-term effects of cyclophosphamide on testicular function","volume":"Ed 291","author":"Watson","year":"1985","journal-title":"Br Med J Clin Res"},{"key":"10.1016\/j.nephro.2017.03.004_bib0205","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/adc.65.10.1147","article-title":"Eight- and 12-week courses of cyclophosphamide in nephrotic syndrome","volume":"65","author":"Ueda","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nephro.2017.03.004_bib0210","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/PL00013435","article-title":"Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome","volume":"14","author":"Kemper","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.03.004_bib0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-011-1830-0","article-title":"Cyclophosphamide in steroid-dependent nephrotic syndrome","volume":"26","author":"Azib","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2017.03.004_bib0110","first-page":"CD002290","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","volume":"1","author":"Hodson","year":"2008","journal-title":"Cochrane Database Syst Rev"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517305515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517305515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.03.004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:11:52Z","timestamp":1741191112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517305515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1769725517305515"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.03.004","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le cyclophosphamide dans le syndrome n\u00e9phrotique idiopathique\u00a0: r\u00e9sultats et perspectives","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}